Triplet regimen as a novel modality for advanced unresectable hepatocellular carcinoma: A case report and review of literature

Figure 1 The dynamic contrast-enhanced magnetic resonance imaging showed hepatocellular carcinoma, inferior vena cava tumor thrombus and main portal vein tumor thrombus before and after therapy. A-C: Images before treatment (March 2018), the liver tumor (A, ellipse): Inferior vena cava tumor thrombus (IVCTT) (B, arrow), the main portal vein tumor thrombus (MPVTT) (C, arrow); D-F: Images of 2 mo after radiotherapy (June 2018), partial remission of the tumor (D, ellipse), partial remission of the IVCTT (E, arrow), and partial remission of the MPVTT (F, arrow); G-I: Images of 36 mo after radiotherapy (May 2021), complete remission of tumor (G), complete remission of IVCTT (H), and complete remission of MPVTT (I).

Figure 2  Target area in radiotherapy was the left part of the tumor.